## SDGR: Schrödinger, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_20 3.2% below STRENGTH zone (4.0-10.0%); PEG 1.30 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($16.72)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. KeyBanc reiterates Overweight rating on Schrodinger stock with $28 price target**
- Source: Investing.com | 20251204T043144 | Bullish | Relevance: 100%
- KeyBanc has reiterated its Overweight rating and $28 price target for Schrodinger (NASDAQ:SDGR) after meetings with company executives. The firm highlights Schrödinger's strategic shift from cash-intensive clinical development to a software platform for drug discovery, noting the company's strong financial position and an attractive valuation. This pivot toward profitability positions Schrodinger as a compelling investment opportunity.

**2. American Century Companies Inc. Purchases 84,172 Shares of Schrodinger, Inc. $SDGR**
- Source: MarketBeat | 20251203T131017 | Somewhat-Bullish | Relevance: 100%
- American Century Companies Inc. increased its stake in Schrodinger, Inc. (NASDAQ:SDGR) by 8.4% in the second quarter, acquiring an additional 84,172 shares, bringing their total ownership to 1,086,551 shares valued at $21.86 million. Despite beating quarterly revenue and EPS estimates, Schrodinger remains unprofitable with a negative net margin. Analyst consensus currently rates the stock as "Hold" with an average target price of $26.00.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 1 ($0.03M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 70.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Blackrock Inc.: 14.8% (-2.2%)
- Gates Foundation Tru: 10.8% (0.0%)
- Vanguard Group Inc: 9.8% (-4.2%)
- Rubric Capital Manag: 8.2% (+5.4%)
- Sumitomo Mitsui Trus: 7.1% (+24.8%)

### Key Risks

1. High short interest (23.2%, 11.2 days to cover): squeeze risk or crowded bearish bet.
2. Long-term trend broken: trading 12.3% below SMA200.
3. Market regime shift could impact high-beta names disproportionately.

### Catalysts

- Momentum building: MRS_20 improving +7.0% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.30 suggests fair value with growth premium. Balance sheet: strong liquidity (3.2x). Revenue growth strong at 20% YoY. Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $1.3B |
| Beta | 1.57 |
| 52W Range | $15.99 - $28.47 |
| Short Interest | 23.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.30 |
| Forward P/E | N/A |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | None |

### Technicals

MRS_20 strengthening from -3.9% to 3.2% (+7.0% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.8pp (needs >4.0% for momentum thesis). MRS_5 at 4.4% confirms short-term momentum alignment. AM_20 at 5.3% shows strong absolute momentum above own 20MA. Outperforming sector by 4.6pp, stock-specific strength. Below SMA200 (0.88x), long-term trend not supportive. RSI neutral at 52. OFD pattern: +MTL (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.17% (CS: 75) | Neutral |
| RSI_14 | 52.3 | Neutral |
| MACD Histogram | 0.19 | Bullish |
| vs SMA20 | 1.053x | Above |
| vs SMA50 | 0.952x | Below |
| vs SMA200 | 0.877x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $18.42
- **Stop Loss:** $16.72 (9.2% risk)
- **Target:** $20.12 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 294
- **Position Value:** $5,415.48
- **Portfolio %:** 5.42%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at 15.78 indicates calm conditions but breadth at 53% suggests narrow participation. Fed policy remains neutral with 42 days to next meeting, supporting steady positioning with sector selectivity.*

### Earnings

**Next:** 2026-02-25 (Est: $-0.17)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-0.74 | $-0.57 | +23.0% |
| 2025Q2 | $-0.64 | $-0.65 | -1.6% |
| 2025Q1 | $-0.81 | $-0.64 | +21.0% |
| 2024Q4 | $-0.38 | $-0.24 | +36.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*